Asthma Phenotypes, Associated Comorbidities, and Long-Term Symptoms in COVID-19asthmaeosinophilsCOVID-19SARS CoVBackground: It is unclear if asthma and its allergic phenotype are risk factors for hospitalization or severe disease from SARS-CoV-2. Methods: All patients testing positive for SARS-CoV...
Reports on the topic of asthma as risk factor for COVID-19 infection were included in this review. Results: 29 studies were included in this review. Given that overexpression of ACE2 in rhinovirus infections, and activation of ACE2 regulates many antiviral responses to cytokines. This may ...
"We're not seeing a lot of patients with asthma," said Dr. Bushra Mina, a pulmonary and critical care physician at Lenox Hill Hospital in New York City, which has treated more than 800 COVID cases. The more common risk factors, he added, are "morbid obesity, diabetes and chronic hear...
"We found that asthma and obesity are connected in COVID-19 patients, which means that obesity coupled with asthma puts a patient at a significantly higher risk. This is the first report, to our knowledge, to study the role of asthma on the outcome of COVID-19 patients." Mahdavinia's ...
Asthma prevalence rate was 7% among positive patients and 11% among negative patients.28 A case series of 5700 patients with confirmed COVID-19 in the New York City area provides characteristics of hospitalized patients; asthma prevalence was determined as 9%.29 The International Severe Acute ...
Does asthma increase severity of COVID-19? - researchers suggest people with asthma not at higher risk, but more studies are needed.
Is asthma protective against COVID?doi:10.1111/all.14426Giulia CarliLorenzo CecchiJustin StebbingPaola ParronchiAlessandro FarsiAllergy
Covid-19, Angiogenesis, and ARDS Endotypes. The SARS-CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of acute respiratory distress syndrome (ARDS), which has been associated with severe coronavirus disease 2019 (Covid-19). ARDS has long been rec... L Hariri...
Long COVID outcomes in an asthmatic cohort and its implications for asthma control 2023, Respiratory Medicine Citation Excerpt : Patients with T2-asthma had less chest pain after 12 months post-COVID (OR = 0.319) (table-3). These results are consistent with previous studies, suggesting the po...
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, Silvio Steiner, Anita Dreher, Paulina Wawrzyniak, Beate Rückert,...